Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Seek Labs

News headline image
Seek Labs Awarded $2 Million Federal Grant for a Novel CRISPR-Based, Mutation-Resistant Therapeutic to Combat Avian Flu in Partnership with Canadian Food Inspection Agency
From Seek Labs
Via Business Wire
News headline image
Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever
From Seek Labs
Via Business Wire
News headline image
Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™
From Seek Labs
Via Business Wire
News headline image
Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™
From Seek Labs
Via Business Wire
News headline image
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV)
From Seek Labs
Via Business Wire
News headline image
Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™ to Advance Development of a Pan-Target, Programmable Therapeutic
From Seek Labs
Via Business Wire
News headline image
Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform
From Seek Labs
Via Business Wire
News headline image
Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™, Accelerating Therapeutic Discovery for Chikungunya, West Nile Virus, and Zika
From Seek Labs
Via Business Wire
News headline image
Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
From Seek Labs
Via Business Wire
News headline image
Seek Labs’ BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
From Seek Labs
Via Business Wire
News headline image
Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks
From Seek Labs
Via Business Wire
News headline image
Seek Labs Unveils BioSeeker™
From Seek Labs
Via Business Wire
News headline image
Seek Labs Appoints Kim Wirthlin as Chief Strategy Officer
From Seek Labs
Via Business Wire
News headline image
Seek Labs to Sponsor and Exhibit at the 2024 Next Generation Dx Summit in Washington, D.C.
From Seek Labs
Via Business Wire
News headline image
Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development
From Seek Labs
Via Business Wire
News headline image
Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatments
From Seek Labs
Via Business Wire
News headline image
Seek Labs Welcomes Esteemed Diagnostics Industry Innovator and Executive, Dr. Randy Rasmussen, PhD, to Board of Directors
From Seek Labs
Via Business Wire
News headline image
Seek Labs Appoints Renowned Life Sciences Innovator, Dr. Michael Paul, PhD, to Board of Directors
From Seek Labs
Via Business Wire
News headline image
Seek Labs Welcomes Cindy Dunkle, Accomplished HR Leader with Extensive Life Sciences Experience, to Board of Directors
From Seek Labs
Via Business Wire
News headline image
Seek Labs Welcomes Alison O’Mahony, PhD as new Vice President of Pharmaceutical Research
From Seek Labs
Via Business Wire
News headline image
Seek Labs Invited to Present at BIO CEO & Investor Conference
From Seek Labs
Via Business Wire
News headline image
Seek Labs Announces Completion of Office Expansion to Support Business Growth
From Seek Labs
Via Business Wire
News headline image
Seek Labs Unveils SeekIt
From Seek Labs
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.